AstraZeneca asthma drug more effective during attack than steroids, study finds
Portfolio Pulse from
A recent study found that AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during asthma attacks than traditional oral steroids, reducing the need for further treatment by 30%.
November 28, 2024 | 12:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AstraZeneca's Fasenra has been shown to be more effective than traditional oral steroids in treating severe asthma attacks, reducing the need for further treatment by 30%.
The study highlights Fasenra's superior efficacy over a long-standing standard treatment, which could lead to increased adoption and sales, positively impacting AstraZeneca's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100